🔗 Share this article

Treasury head Reeves has revealed she is planning "focused steps to tackle cost of living issues" in the upcoming Budget.

In comments to media outlets, she emphasized that reducing inflation is a collective duty of both the government and the central bank.

The United Kingdom's price growth is forecast to be the most elevated among the Group of Seven industrialized countries this calendar year and next.

Potential Energy Bill Measures

Reports indicate the administration could intervene to bring down energy bills, for instance by slashing the current 5% rate of VAT applied on energy supplies.

A further approach is to lower some of the regulatory levies presently included in bills.

Fiscal Constraints and Expert Predictions

The government will obtain the latest assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for these actions.

The consensus from the majority of experts is that the Chancellor will have to declare tax rises or expenditure reductions in order to meet her declared borrowing rules.

Previously on Thursday, estimates suggested there was a £22 billion gap for the chancellor to resolve, which is at the lower end of forecasts.

"It is a joint responsibility between the Bank of England and the government to bear down further on some of the drivers of inflation," Reeves stated to the BBC in Washington, at the yearly gatherings of the IMF and global financial institution.

Revenue Pledges and Global Concerns

While a great deal of the attention has been on probable tax increases, the chancellor said the latest data from the OBR had not altered her commitment to manifesto promises not to increase rates on income tax, VAT or National Insurance.

She attributed an "unpredictable global environment" with rising international and commercial issues for the Budget revenue measures, probably to be targeted on those "most able to pay."

International Trade Tensions

Addressing concerns about the UK's trade ties with the Asian nation she said: "The UK's national security always are paramount."

Recent declaration by Chinese authorities to strengthen trade restrictions on critical minerals and other materials that are key for high-technology manufacturing led US President the US President to suggest an extra 100% tariff on imports from the Asian country, raising the possibility of an all-out trade war between the two global powers.

The US Treasury Secretary labeled the Chinese move "economic coercion" and "a global supply chain control attempt."

Questioned on considering the American proposal to join its dispute with China, the Chancellor said she was "extremely troubled" by Chinese actions and urged the Chinese government "not to put up barriers and limit trade."

She said the action was "harmful for the global economy and creates additional challenges."

"In my view there are fields where we should challenge China, but there are also significant prospects to trade with China's economy, including banking sector and other areas of the economic system. We've got to achieve that balance correct."

The Treasury chief also confirmed she was collaborating with international partners "regarding our own essential resources strategy, so that we are more independent."

Health Service Drug Pricing and Investment

The Chancellor also recognized that the price the NHS pays for medicines could go up as a result of ongoing negotiations with the Trump administration and its drugs companies, in exchange for reduced taxes and investment.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or canceling projects in the United Kingdom, with several attributing the low prices they are getting.

Last month, the government science advisor said the cost the health service pays for medicines would have to go up to stop firms and pharmaceutical investment departing from the United Kingdom.

The Chancellor told the BBC: "We have seen as a result of the pricing regime, that medical research, recent pharmaceuticals have not been available in the United Kingdom in the manner that they are in other European countries."

"The objective is to guarantee that patients receiving treatment from the National Health Service are can obtain the top essential medicines in the world. And so we are reviewing this situation, and... looking to secure additional capital into the UK."